D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 51 Citations 11,723 118 World Ranking 3186 National Ranking 1279

Research.com Recognitions

Awards & Achievements

2001 - Sonnenwirth Award for Leadership in Clinical Microbiology, American Society for Microbiology

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Antibiotics
  • Disease

Peter H. Gilligan focuses on Microbiology, Cystic fibrosis, Internal medicine, Immunology and Lung. His Microbiology study frequently draws connections to adjacent fields such as Head and neck. His Cystic fibrosis research is multidisciplinary, relying on both Respiratory tract, Pseudomonas aeruginosa, Transmission, Sputum and Severe disease.

His Significant risk study, which is part of a larger body of work in Internal medicine, is frequently linked to In patient, bridging the gap between disciplines. His Immunology course of study focuses on Nontuberculous mycobacteria and Mycobacterium abscessus. His work in Gastroenterology covers topics such as Surgery which are related to areas like Burkholderia cepacia complex.

His most cited work include:

  • Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections (1113 citations)
  • Emergence of Vancomycin Resistance in Coagulase-Negative Staphylococci (482 citations)
  • Microbiology of airway disease in patients with cystic fibrosis (479 citations)

What are the main themes of his work throughout his whole career to date?

Microbiology, Cystic fibrosis, Internal medicine, Immunology and Clostridium difficile are his primary areas of study. As a member of one scientific family, Peter H. Gilligan mostly works in the field of Microbiology, focusing on Burkholderia and, on occasion, Bacilli. His Cystic fibrosis research includes themes of Lung transplantation, Lung, Sputum and Mycobacterium abscessus.

His Internal medicine study incorporates themes from Gastroenterology, Antibiotics and Surgery. His studies deal with areas such as Respiratory system and Staphylococcus aureus as well as Immunology. Virology is closely connected to Immunoassay in his research, which is encompassed under the umbrella topic of Clostridium difficile.

He most often published in these fields:

  • Microbiology (46.21%)
  • Cystic fibrosis (40.91%)
  • Internal medicine (28.03%)

What were the highlights of his more recent work (between 2014-2019)?

  • Cystic fibrosis (40.91%)
  • Microbiology (46.21%)
  • Internal medicine (28.03%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Cystic fibrosis, Microbiology, Internal medicine, Mycobacterium abscessus and Immunology. The concepts of his Cystic fibrosis study are interwoven with issues in Antibiotics, Lung, Bronchiectasis, Intensive care medicine and Sputum. His work in the fields of Ocular Infections overlaps with other areas such as Infectious disease diagnosis.

The Internal medicine study combines topics in areas such as Gastroenterology, Clostridium difficile and Daptomycin. His Mycobacterium abscessus study integrates concerns from other disciplines, such as Clarithromycin, Clinical efficacy, Pseudomonas aeruginosa and Single Center. His work on Atopic dermatitis, Immune system and Pathogenesis as part of general Immunology study is frequently linked to Pediatric health, therefore connecting diverse disciplines of science.

Between 2014 and 2019, his most popular works were:

  • Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium. (254 citations)
  • A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology (162 citations)
  • Cost Savings Realized by Implementation of Routine Microbiological Identification by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry (70 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Antibiotics
  • Disease

Peter H. Gilligan spends much of his time researching Cystic fibrosis, Microbiology, Immunology, Lung and Mycobacterium abscessus. His work deals with themes such as Anaerobic bacteria, Colony-forming unit, Sputum, Anaerobic exercise and Bronchoalveolar lavage, which intersect with Cystic fibrosis. His study in Microbiology is interdisciplinary in nature, drawing from both Aerobic bacteria and Head and neck.

His Immunology study which covers Antibiotics that intersects with Pathogen, Pseudomonas aeruginosa, Pulmonary inflammation and Chronic infection. His Lung research integrates issues from Antibiotic resistance and Drug resistance. As a part of the same scientific family, Peter H. Gilligan mostly works in the field of Mycobacterium abscessus, focusing on Nontuberculous mycobacteria and, on occasion, Burkholderia, Multiple drug resistance and Epidemiology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections

Christina M Surawicz;Lawrence J Brandt;David G Binion;Ashwin N Ananthakrishnan.
The American Journal of Gastroenterology (2013)

1999 Citations

Emergence of Vancomycin Resistance in Coagulase-Negative Staphylococci

Richard S. Schwalbe;Jack T. Stapleton;Peter H. Gilligan.
The New England Journal of Medicine (1987)

755 Citations

Microbiology of airway disease in patients with cystic fibrosis

Peter H. Gilligan.
Clinical Microbiology Reviews (1991)

704 Citations

A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2013 Recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)a

Ellen Jo Baron;J. Michael Miller;Melvin P. Weinstein;Sandra S. Richter.
Clinical Infectious Diseases (2013)

581 Citations

Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium.

Josephine M Bryant;Josephine M Bryant;Dorothy M Grogono;Dorothy M Grogono;Daniela Rodriguez-Rincon;Isobel Everall.
Science (2016)

416 Citations

A Pilot Study of Aerosolized Amiloride for the Treatment of Lung Disease in Cystic Fibrosis

Michael R Knowles;Nina L. Church;William E. Waltner;James R Yankaskas.
The New England Journal of Medicine (1990)

388 Citations

Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis.

Charles R. Esther;Denise A. Esserman;Peter Gilligan;Alan Kerr.
Journal of Cystic Fibrosis (2010)

352 Citations

A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology

J. Michael Miller;Matthew J. Binnicker;Sheldon Campbell;Karen C. Carroll.
Clinical Infectious Diseases (2018)

329 Citations

Breakthrough Pneumococcal Bacteremia in Patients Being Treated with Azithromycin and Clarithromycin

Meera A. Kelley;David J. Weber;Peter Gilligan;Myron S. Cohen.
Clinical Infectious Diseases (2000)

294 Citations

Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type.

Robert M. Aris;Jonathan C. Routh;Jonathan C. Routh;John J. LiPUMA;John J. LiPUMA;David G. Heath;David G. Heath.
American Journal of Respiratory and Critical Care Medicine (2001)

286 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Peter H. Gilligan

John J. LiPuma

John J. LiPuma

University of Michigan–Ann Arbor

Publications: 65

Laurent Kremer

Laurent Kremer

Institut de Recherche en Infectiologie de Montpellier (IRIM)

Publications: 52

Peter Vandamme

Peter Vandamme

Ghent University

Publications: 49

Scott C. Bell

Scott C. Bell

University of Queensland

Publications: 33

Tom Coenye

Tom Coenye

Ghent University

Publications: 32

Jane L. Burns

Jane L. Burns

University of Washington

Publications: 30

Mark H. Wilcox

Mark H. Wilcox

University of Leeds

Publications: 29

Niels Høiby

Niels Høiby

University of Copenhagen

Publications: 29

Richard C. Boucher

Richard C. Boucher

University of North Carolina at Chapel Hill

Publications: 28

Lisa Saiman

Lisa Saiman

Columbia University

Publications: 27

Alexander Tomasz

Alexander Tomasz

Rockefeller University

Publications: 25

Jean-Louis Gaillard

Jean-Louis Gaillard

Hôpital Ambroise-Paré

Publications: 23

Miguel A. Valvano

Miguel A. Valvano

Queen's University Belfast

Publications: 23

Jean-Louis Herrmann

Jean-Louis Herrmann

Versailles Saint-Quentin-en-Yvelines University

Publications: 23

John R. W. Govan

John R. W. Govan

University of Edinburgh

Publications: 23

Claire E. Wainwright

Claire E. Wainwright

University of Queensland

Publications: 23

Trending Scientists

Roni Michaely

Roni Michaely

University of Hong Kong

Nicolas Ducheneaut

Nicolas Ducheneaut

Quantic Foundry

Jim Swithenbank

Jim Swithenbank

University of Sheffield

Maria Bryszewska

Maria Bryszewska

University of Łódź

Maria Valnice Boldrin Zanoni

Maria Valnice Boldrin Zanoni

Sao Paulo State University

Heloisa Beraldo

Heloisa Beraldo

Universidade Federal de Minas Gerais

Stephen J. Tapscott

Stephen J. Tapscott

Fred Hutchinson Cancer Research Center

W. Gary Sprules

W. Gary Sprules

University of Toronto

Jennifer A. Leonard

Jennifer A. Leonard

Spanish National Research Council

Joshua J. Millspaugh

Joshua J. Millspaugh

University of Montana

James E. Gardner

James E. Gardner

The University of Texas at Austin

David C. S. Beddows

David C. S. Beddows

University of Birmingham

Jennifer I. Luebke

Jennifer I. Luebke

Boston University

Alexandra M. Levine

Alexandra M. Levine

City Of Hope National Medical Center

Jan Selmer

Jan Selmer

Aarhus University

Harold S. Luft

Harold S. Luft

Palo Alto Medical Foundation

Something went wrong. Please try again later.